The PE Ratio as of December 2025 (TTM) for Sun Pharma Advanced Research Company Limited (SPARC.NS) is -17.87

According to Sun Pharma Advanced Research Company Limited’s latest financial reports and current stock price. The company's current PE Ratio is -17.87. This represents a change of -10.15% compared to the average of -19.89 of the last 4 quarters.

Sun Pharma Advanced Research Company Limited (SPARC.NS) Historical PE Ratio (quarterly & annually)

How has SPARC.NS PE Ratio performed in the past?

The mean historical PE Ratio of Sun Pharma Advanced Research Company Limited over the last ten years is -38.39. The current -17.87 PE Ratio has changed 4.56% with respect to the historical average. Over the past ten years (40 quarters), SPARC.NS's PE Ratio was at its highest in in the March 2018 quarter at 957.37. The PE Ratio was at its lowest in in the September 2018 quarter at -840.00.

Sun Pharma Advanced Research Company Limited (SPARC.NS) PE Ratio by Quarter and Year

Discovering the peaks and valleys of Sun Pharma Advanced Research Company Limited PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Sun Pharma Advanced Research Company Limited (SPARC.NS) Average PE Ratio

How has SPARC.NS PE Ratio performed in the past?

The current PE Ratio of Sun Pharma Advanced Research Company Limited (SPARC.NS) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

Sun Pharma Advanced Research Company Limited (SPARC.NS) PE Ratio vs. Peers

How is SPARC.NS’s PE Ratio compared to its peers?

Sun Pharma Advanced Research Company Limited’s PE Ratio is greater than Suven Life Sciences Limited (-19.91), greater than Suven Life Sciences Limited (-19.91), less than Aarti Drugs Limited (18.32), less than Aarti Drugs Limited (18.32), less than RPG Life Sciences Limited (16.81), less than RPG Life Sciences Limited (16.81), less than Innova Captab Limited (32.44), less than Orchid Pharma Limited (82.84), less than Gufic Biosciences Limited (56.70), less than Gufic Biosciences Limited (56.70),

Build a custom stock screener for Sun Pharma Advanced Research Company Limited (SPARC.NS) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Sun Pharma Advanced Research Company Limited using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Sun Pharma Advanced Research Company Limited (SPARC.NS) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Sun Pharma Advanced Research Company Limited or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.